mecamylamine has been researched along with Acute Brain Injuries in 2 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, DR | 1 |
| Björnsson, E | 1 |
| Bergquist, F | 1 |
| Nissbrandt, H | 1 |
| Griffith, ER | 1 |
| Taylor, N | 1 |
| DeLateur, BJ | 1 |
| Lehmann, JF | 1 |
2 other studies available for mecamylamine and Acute Brain Injuries
| Article | Year |
|---|---|
Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Topics: Analysis of Variance; Animals; Area Under Curve; Brain Injuries; Chromatography, High Pressure Liqui | 2010 |
Orthostatic hypertension following brain trauma: report of a case.
Topics: Adolescent; Brain Edema; Brain Injuries; Follow-Up Studies; Guanethidine; Hematoma, Subdural; Humans | 1971 |